EX-23.2 14 peregrine_s3-ex232.txt EXHIBIT 23.2 CONSENT OF INDEPENDENT AUDITORS We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-3) and related Prospectus of Peregrine Pharmaceuticals, Inc. for the registration of 22,486,233 shares of its common stock and to the incorporation by reference therein of our report dated June 21, 2002, (except for Notes 1 and 14, as to which the date is August 13, 2002) with respect to the consolidated financial statements and schedule of Peregrine Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended April 30, 2002, filed with the Securities and Exchange Commission. /s/ ERNST & YOUNG LLP Orange County, California August 30, 2002